Medicare Enrolled
Dr. Payam Shakouri, M.D.
Nephrology · Poughkeepsie, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shakouri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shakouri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shakouri
Dr. Payam Shakouri is a nephrology specialist in Poughkeepsie, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Shakouri performed 3,731 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shakouri received a total of $817,897 from 41 pharmaceutical and/or device companies across 1519 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shakouri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 12% volume in NY
$817,897 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,731
Medicare services
Top 12% in NY for nephrology
Not available
Unique patients (not deduplicated)
$350
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
854 | $101 | $217 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $107 | $232 |
| Injection, pegloticase, 1 mg | 416 | $2,198 | $5,606 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
378 | $67 | $151 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
327 | $295 | $616 |
| Hemodialysis procedure requiring repeated evaluation A hemodialysis treatment that involves repeated evaluation during the procedure. |
295 | $86 | $260 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
217 | $147 | $422 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
188 | $69 | $157 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
91 | $60 | $200 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
62 | $13 | $34 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
60 | $111 | $288 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
56 | $25 | $63 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
54 | $245 | $511 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $138 | $355 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
52 | $115 | $294 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
52 | $4 | $11 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
50 | $240 | $503 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
37 | $72 | $250 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $171 | $300 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
21 | $230 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.4% high complexity
38.6% medium
60.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$817,897
Total received (2018-2024)
Avg $116,842/year across 7 years
Top 0% in NY for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,519
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$174,674
2023
$170,888
2022
$192,861
2021
$127,134
2020
$45,143
2019
$94,210
2018
$12,987
Payments by company (2024)
Amgen Inc.
$98,326
ANI Pharmaceuticals, Inc.
$24,638
Travere Therapeutics, Inc.
$17,221
Bayer Healthcare Pharmaceuticals Inc.
$17,165
Aurinia Pharma U.S., Inc.
$14,395
AstraZeneca Pharmaceuticals LP
$1,702
Mallinckrodt Hospital Products Inc.
$145
Novartis Pharmaceuticals Corporation
$112
NXSTAGE MEDICAL, INC.
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
OPKO Pharmaceuticals, LLC
$103
Lilly USA, LLC
$99
Vifor Pharma, Inc.
$98
Kyowa Kirin, Inc.
$92
CALLIDITAS THERAPEUTICS US INC.
$78
Alexion Pharmaceuticals, Inc.
$69
Otsuka America Pharmaceutical, Inc.
$64
Novo Nordisk Inc
$34
Takeda Pharmaceuticals U.S.A., Inc.
$27
Alnylam Pharmaceuticals Inc.
$25
Fresenius USA Marketing, Inc.
$25
GlaxoSmithKline, LLC.
$23
AKEBIA THERAPEUTICS INC
$20
Top 3 companies account for 80.3% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$476,094
Amgen Inc.
$99,042
Bayer Healthcare Pharmaceuticals Inc.
$54,067
Bayer HealthCare Pharmaceuticals Inc.
$44,321
ANI Pharmaceuticals, Inc.
$39,878
Aurinia Pharma U.S., Inc.
$37,772
Travere Therapeutics, Inc.
$29,061
Horizon Pharma plc
$11,913
AstraZeneca Pharmaceuticals LP
$9,891
Vifor Pharma, Inc.
$6,539
Relypsa, Inc.
$2,112
GlaxoSmithKline, LLC.
$1,907
Mallinckrodt Hospital Products Inc.
$859
Otsuka America Pharmaceutical, Inc.
$440
OPKO Pharmaceuticals, LLC
$408
Alexion Pharmaceuticals, Inc.
$371
Novo Nordisk Inc
$354
Fresenius USA Marketing, Inc.
$308
Mallinckrodt LLC
$303
Calliditas Therapeutics US Inc.
$295
Boehringer Ingelheim Pharmaceuticals, Inc.
$238
Exeltis, USA Inc.
$237
Novartis Pharmaceuticals Corporation
$196
Mallinckrodt Enterprises LLC
$186
CALLIDITAS THERAPEUTICS US INC.
$138
Lilly USA, LLC
$132
Alnylam Pharmaceuticals Inc.
$115
AKEBIA THERAPEUTICS INC
$110
NXSTAGE MEDICAL, INC.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$95
Kyowa Kirin, Inc.
$92
Shire North American Group Inc
$80
Keryx Biopharmaceuticals, Inc.
$58
GENZYME CORPORATION
$53
Abbott Laboratories
$30
Janssen Pharmaceuticals, Inc
$20
Esperion Therapeutics, Inc.
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$14
Genentech USA, Inc.
$13
Allergan Inc.
$13
Top 3 companies account for 76.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Auryxia · BENLYSTA · BYSTOLIC · Crysvita · Dialyzers · ENTRESTO · FABRY-DISEASE · FARXIGA · FREESTYLE LIBRE 2 · Fabhalta · FreeStyle Libre 2 · GATTEX · GIVLAARI · INVOKANA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LIVTENCITY · LOKELMA · LUPKYNIS · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NXSTAGE SYSTEM ONE · OXLUMO · Otezla · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · Prolia · RAYALDEE · RYBELSUS · Rayaldee · Repatha · Rituxan · Rybelsus · SAMSCA · SOLIRIS · SPIRIVA RESPIMAT · TARPEYO · TAVNEOS · TERLIVAZ · TRADJENTA · TRULICITY · Tavneos · Tresiba · ULTOMIRIS · Ultomiris · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
15
County median income
$97,273
Nearest hospital to ZIP centroid (approximate)
VASSAR BROTHERS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shakouri is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shakouri experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Shakouri performed 854 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shakouri receive payments from pharmaceutical companies?
Yes. Dr. Shakouri received a total of $817,897 from 41 companies across 1,519 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shakouri's costs compare to other nephrologists in Poughkeepsie?
Dr. Shakouri's average Medicare payment per service is $350. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shakouri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Poughkeepsie
Browse nephrologists in Poughkeepsie ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NY
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NY
Which NY nephrologists receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology